BRIEF-Inhibrx Biosciences Announces Departure Of CSO And Appointments Of New CSO And President

Reuters
02 Apr
BRIEF-<a href="https://laohu8.com/S/INBX">Inhibrx Biosciences</a> Announces Departure Of CSO And Appointments Of New CSO And President

April 1 (Reuters) - Inhibrx Biosciences Inc INBX.O:

  • INHIBRX BIOSCIENCES ANNOUNCES DEPARTURE OF CSO AND APPOINTMENTS OF NEW CSO AND PRESIDENT

  • INHIBRX BIOSCIENCES INC - APPOINTS CARLOS BAIS AS CSO AND DAVID MATLY AS PRESIDENT

  • INHIBRX BIOSCIENCES INC - BRENDAN ECKELMAN TO ESTABLISH NEW PRIVATE BIOTECH COMPANY AS CEO

  • INHIBRX BIOSCIENCES INC - ENTERS EXCLUSIVE LICENSE AGREEMENT WITH NEW COMPANY

Source text: ID:nPn71fyha

Further company coverage: INBX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10